Is there more than one road to melanoma?

Lancet

Volumn 363, Issue 9410, 2004, Pages 728-730

  Rivers, Jason K ^a,b,c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d Skin Care Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 1 RECEPTOR;

DNA POLYMORPHISM; HUMAN; MEDICAL INFORMATION; MELANOCYTE; MELANOMA; NEVUS; PRIORITY JOURNAL; PUBLIC HEALTH; PUVA; REVIEW; SUN EXPOSURE; ULTRAVIOLET RADIATION; WORKPLACE;

EID: 1542361349     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)15649-3     Document Type: Short Survey

References (31)

1. Bevona C., Sober A.J. Melanoma incidence trends. Dermatol Clin. 20:2002;589-595.
2. De Vries E., Bray F.I., Coebergh J.W., Parkin D.M. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer. 107:2003;119-126.
3. Elwood J.M. Melanoma and sun exposure. Semin Oncol. 23:1996;650-666.
4. Elwood J.M., Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer. 73:1997;198-203.
5. Hakansson N., Floderus B., Gustavsson P., Feychting M., Hallin N. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology. 12:2001;552-557.
6. Evans R.D., Kopf A.W., Lew R.A., et al. Risk factors for the development of malignant melanoma I: review of case-control studies. J Dermatol Surg Oncol. 14:1988;393-408.
7. Bauer J., Garbe C. Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res. 16:2003;297-306.
8. Kelly J.W., Rivers J.K., MacLennan R., et al. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol. 30:1994;40-48.
9. Maclennan R., Kelly J.W., Rivers J.K., Harrison S.L. The Eastern Australian childhood nevus study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. J Am Acad Dermatol. 48:2003;367-375.
10. Smolle J., Kaddu S., Kerl H. Non-random spatial association of melanoma and naevi - a morphometric analysis. Melanoma Res. 9:1999;407-412.
11. Marks R., Dorevitch A.P., Mason G. Do all melanomas come from "moles"? A study of the histological association between melanocytic naevi and melanoma. Australas J Dermatol. 31:1990;77-80.
12. Bevona C., Goggins W., Quinn T., Fullerton J., Tsao H. Cutaneous melanomas associated with nevi. Arch Dermatol. 139:2003;1620-1624.
13. Green A. A theory of the site distribution of melanomas: Queensland, Australia. Cancer Causes Control. 3:1992;513-516.
14. Whiteman D.C., Parsons P.G., Green A.D. P53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer. 77:1998;843-848.
15. Whiteman D.C., Watt P., Purdie D.M., et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 95:2003;806-812.
16. Maldonado J.L., Fridlyand J., Patel H., et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 95:2003;1878-1890.
17. Schaffer J.V., Bolognia J.L. The melanocortin-1 receptor: red hair and beyond. Arch Dermatol. 137:2001;1477-1485.
18. Box N.F., Wyeth J.R., O'Gorman L.E., Martin N.G., Sturm R.A. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet. 6:1997;1891-1897.
19. Smith R., Healy E., Siddiqui S., et al. Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol. 111:1998;119-122.
20. Healy E., Flannagan N., Ray A., et al. Melanocortin-1 receptor gene and sun sensitivity in individuals without red hair. Lancet. 355:2000;1072-1073.
21. Palmer J.S., Duffy D.L., Box N.F., et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet. 66:2000;176-186.
22. Wenczl E., Van der Schans G.P., Roza L., et al. (Pheo)melanin photosensitizes UVA-induced DNA damage in cultured human melanocytes. J Invest Dermatol. 111:1998;678-682.
23. Boyd A.S., Shyr Y., King L.E. Jr. Basal cell carcinoma in young women: an evaluation of the association of tanning bed use and smoking. J Am Acad Dermatol. 46:2002;706-709.
24. Karagas M.R., Stannard V.A., Mott L.A., Slattery M.J., Spencer S.K., Weinstock M.A. Use of tanning devices and risk for basal cell and squamous cell skin cancers. J Natl Cancer Inst. 94:2002;224-226.
25. Veierod M.B., Weiderpass E., Thorn M., et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst. 95:2003;1530-1538.
26. Stern R.S. Genital tumours among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation: the Photochemotherapy Follow-up Study. N Engl J Med. 322:1990;1093-1097.
27. Stern R.S., Nichols K.T., Vakeva L.H. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): the PUVA Follow-Up Study. N Engl J Med. 336:1997;1041-1045.
28. Green A., Williams G., Neale R., et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinoma of the skin: a randomised controlled trial. Lancet. 354:1999;723-729.
29. Darlington S., Williams G., Neale R., Frost C., Green A. A randomized controlled trial to assess sunscreen application and betacarotene supplementation in the prevention of solar keratoses. Arch Dermatol. 139:2003;451-455.
30. Gallagher R.P., Rivers J.K., Lee T.K., Bajdik C.D., McLean D.I., Coldman A.J. Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial. JAMA. 283:2000;2955-2960.
31. Diffey B. Sunscreen isn't enough. J Photchem Photobiol B. 64:2001;105-108.